medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2019, Number 4

<< Back Next >>

Rev Mex Oftalmol 2019; 93 (4)

Infection by Serratia marcescens in porous orbital implant

Fernández-Montalvo L, Ibáñez-Flores N, Cifuentes-Canorea P, Mendoza-García BC

Language: Spanish
References: 12
Page: 200-202
PDF size: 164.54 Kb.


ABSTRACT

Case report: We report a case of a patient who underwent left eye evisceration and porous polyethylene implant insertion after a traffic accident 3 years before. He developed recurrent implant exposition. Conjunctival swab culture showed growth of Serratia marcescens, a bacillus associated with nosocomial infections, especially in pediatric intensive care units, but rare in adults. Discussion: Implant infection should be suspected when there is persistent discharge and conjunctival dehiscence after implant insertion. Therefore, all patients with an implant exposure must undergo a culture for infection detection. When even appropriate antibiotics cannot control the infection, the implant must be removed.


REFERENCES

  1. Jordan DR, Bawazeer A. Experience with 120 synthetic hydroxyapatite implants (FCI3). Ophthal Plast Reconstr Surg. 2001;17:184-90.

  2. Jordan DR, Brownstein S, Faraji H. Clinicopathologic analysis of 15 explanted hydroxyapatite implants. Ophtalm Plastic Reconstructive Surg. 2004;20:285-90.

  3. Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology. 1994; 101:1688-95.

  4. Lee S, Maronian N, Most SP, Whipple ME, McCulloch TM, Stanley RB, et al. Porous high-density polyethylene for orbital reconstruction. Arch Otolaryngol Head Neck Surg. 2005;131:446-50.

  5. Lee JH, Yang SW, Choi WV. Clinical outcome and complications of Medpor orbital implant. J Korean Ophthalmol Soc. 2001;42:933-8.

  6. Jung SK, Cho WK, Paik JS, Yang SW. Long-term surgical outcomes of porous polyethylene orbital implants: a review of 314 cases. Br J Ophthalmol. 2012;96(4):494-8.

  7. Alwitry A, West S, King J, Foss AJ, Abercrombie LC. Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg. 2007;23(1)11-5.

  8. You Jr, Seo JH, Kim YH, Choi WC. Six cases of bacterial infection in porous orbital implants. Jpn J Ophthalmol. 2003;47(5):512-8.

  9. Voelz A, Müller A, Gillen J, Le C, Dresbach T, Engekhart S, et al. Outbreaks of Serratia marcescens in neonatal and pediatric intensive care units: clinical aspects, risk factors and management. Int J Hyg Environm Health. 2010;213:79-87.

  10. Equi RA, Green WR. Endogenous Serratia marcescens endophthalmitis with dark hypopyon: a case report and review. Surv Ophthalmol. 2001;46:259-68.

  11. Sridhar J, Kuriyan AE, Flynn HW, Smiddy W, Venincasa VD, Miller D. Endophthalmitis caused by Serratia marcescens. Clinica features, antibiotic susceptibilities, and treatment outcomes. Retina. 2015;35:1095-100.

  12. Seyhan T, Borman H, Deniz M. Kocer E. Intranasal porous polyethylene implant extrusion 7 years after insertion in a patient with Hashimoto disease. J Craniofac Surg. 2009;20(1):73-4.




2020     |     www.medigraphic.com